Malouin F, Bryan L E, Shewciw P, Douglas J, Li D, Van den Elzen H, Lapointe J R
Department of Microbiology, University of Calgary Health Sciences Centre, Canada.
J Clin Microbiol. 1988 Oct;26(10):2132-8. doi: 10.1128/jcm.26.10.2132-2138.1988.
In a previous study, we reported that a 5-kilobase Haemophilus influenzae DNA fragment involved in penicillin-binding protein expression could be used as a probe for specific detection of H. influenzae strains (F. Malouin and L. E. Bryan, Mol. Cell. Probes 1:221-232, 1987). Here, we report the ability of this probe to detect H. influenzae in clinical specimens. In a bacterial dot experiment, there was strong hybridization of the 32P-labeled probe to nonencapsulated and serotype a through f H. influenzae strains. The detection of H. influenzae in body fluids was then evaluated by using pooled human serum, urine, cerebrospinal fluid, and sputum as dilution media for H. influenzae, Haemophilus aegyptius, Haemophilus parainfluenzae, and Escherichia coli cells. At 65 degrees C, the probe hybridized to H. influenzae and H. aegyptius (greater than or equal to 10(5) cells) in all fluids. There was no hybridization with the E. coli negative control, and H. parainfluenzae hybridized when greater than or equal to 10(7) cells were used. Experiments performed at 73 and 80 degrees C permitted elimination of H. parainfluenzae hybridization. The detection of H. influenzae in 232 sputa from patients with respiratory tract infections was very specific (96 to 97%) and sensitive (74 to 100%) when the total time of the procedure was sufficient (6 to 24 h) and when the experiments were performed at 80 degrees C. In addition, the probe detected three of three and four of four H. influenzae-infected cerebrospinal fluids and blood cultures, respectively, and did not react with pneumococcus- or streptococcus-infected cerebrospinal fluids. Finally, by using a small-scale procedure, the probe rapidly detected H. influenzae in cerebrospinal fluid and sputum specimens (4 and 8 h, respectively). These results imply prompt diagnosis of H. influenzae infections caused by nonencapsulated and serotype a through f strains.
在先前的一项研究中,我们报道了一个参与青霉素结合蛋白表达的5千碱基流感嗜血杆菌DNA片段可作为特异性检测流感嗜血杆菌菌株的探针(F. 马卢安和L. E. 布赖恩,《分子细胞探针》1:221 - 232,1987年)。在此,我们报道了该探针检测临床标本中流感嗜血杆菌的能力。在细菌斑点实验中,32P标记的探针与非包膜型以及a至f血清型的流感嗜血杆菌菌株发生强烈杂交。然后,通过使用混合的人血清、尿液、脑脊液和痰液作为流感嗜血杆菌、埃及嗜血杆菌、副流感嗜血杆菌和大肠杆菌细胞的稀释介质,对体液中流感嗜血杆菌的检测进行了评估。在65℃时,该探针与所有体液中的流感嗜血杆菌和埃及嗜血杆菌(≥10⁵个细胞)杂交。与大肠杆菌阴性对照无杂交,当使用≥10⁷个细胞时副流感嗜血杆菌发生杂交。在73℃和80℃进行的实验能够消除副流感嗜血杆菌的杂交。当操作总时间足够(6至24小时)且实验在80℃进行时,对232份呼吸道感染患者痰液中流感嗜血杆菌的检测具有很高的特异性(96%至97%)和敏感性(74%至100%)。此外,该探针分别在三份流感嗜血杆菌感染的脑脊液样本中检测出三份,在四份流感嗜血杆菌感染的血培养样本中检测出四份,并且与肺炎球菌或链球菌感染的脑脊液无反应。最后,通过使用小规模操作程序,该探针能快速检测脑脊液和痰液标本中的流感嗜血杆菌(分别为4小时和8小时)。这些结果意味着可迅速诊断由非包膜型以及a至f血清型菌株引起的流感嗜血杆菌感染。